| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 02/19/2009 | CA2705463A1 Anti-inflammatory compounds and uses thereof |
| 02/19/2009 | CA2696314A1 Therapeutic compounds |
| 02/19/2009 | CA2696063A1 Immediate release and sustained release ibuprofen dosing form |
| 02/19/2009 | CA2695878A1 5-membered heterocyclic compound |
| 02/19/2009 | CA2695757A1 Phenylacetic acid compound |
| 02/18/2009 | EP2025749A1 Humanized anti-human osteopontin antibody |
| 02/18/2009 | EP2025680A1 Degranulation inhibitor |
| 02/18/2009 | EP2025676A1 Novel indazole derivative having spiro ring structure in side chain |
| 02/18/2009 | EP2025666A2 Thiolalkyl benzoic acid derivatives |
| 02/18/2009 | EP2025340A1 Plant extracts for the treatment of rheumatoid arthritis |
| 02/18/2009 | EP2024357A2 New heterocyclic compounds for the inhibition of integrins and use thereof |
| 02/18/2009 | EP2024349A2 Novel compounds as cannabinoid receptor ligands and uses thereof |
| 02/18/2009 | EP2024335A1 Novel imidazole derivatives, preparation and user thereof as medicine |
| 02/18/2009 | EP2024323A1 Salts of trimebutine and n-desmethyl trimebutine |
| 02/18/2009 | EP2023727A2 Prostaglandin transporter inhibitors |
| 02/18/2009 | EP1727801B1 Piperazines useful for treating pain |
| 02/18/2009 | EP1569958B1 Methods and materials for treating inflammatory conditions using a polypeptide comprising a self-c5 amino acid segment and a non-self amino acid segment |
| 02/18/2009 | EP1539727B1 Compounds, compositions, and methods for treating cellular proliferative diseases |
| 02/18/2009 | EP1513493B1 Analgesics |
| 02/18/2009 | EP1458757B1 Process for the purification and/or isolation of biologically active granulocyte colony stimulating factor |
| 02/18/2009 | EP1399431B1 Novel nitriles useful as reversible inhibitors of cysteine proteases |
| 02/18/2009 | EP1360178B1 Novel heterocyclic analogs of diphenylethylene compounds |
| 02/18/2009 | EP1028945B9 Substituted pyridine compounds as anti-inflammatory agents |
| 02/18/2009 | CN101370828A Anti-inflammatory dab |
| 02/18/2009 | CN101367877A Monkey monoclonal antibodies specific to human B7.1 and/or B7.2 primatized forms, pharmaceutical compositions |
| 02/18/2009 | CN101367862A Method for quickly and massively separating high purity triptolide from thunder god vine |
| 02/18/2009 | CN101367802A Beta-kabarin alkaloids in quassia wood, preparation method and application thereof |
| 02/18/2009 | CN101366948A Sodium cholate coated liposoluble medicament metacortandracin intercalation hydrotalcite and preparation method thereof |
| 02/18/2009 | CN101366936A Health care umbilicus plaster for regulating menstruation and relieving pain |
| 02/18/2009 | CN101366935A Externally used ultramicro powder traditional Chinese medicine preparation for treating soft tissue injury and preparation method thereof |
| 02/18/2009 | CN101366934A Preparation method of pill for clearing and activating the channels and collaterals |
| 02/18/2009 | CN101366919A Traditional Chinese medicine ointment for treating rheumatism diseases |
| 02/18/2009 | CN101366909A Traditional Chinese medicine for treating common cold |
| 02/18/2009 | CN101366889A Plaster for treating rheumatic arthritis and preparation method |
| 02/18/2009 | CN101366886A Detumescent medicament |
| 02/18/2009 | CN101366875A Quality control method and uses of antirheumatic medicament |
| 02/18/2009 | CN101366845A Ointment for treating ache of neck, shoulder, waist and leg |
| 02/18/2009 | CN101366843A Traditional Chinese medicine pain-relieving powder prescription |
| 02/18/2009 | CN101366730A Glucosamine donkey-hide gelatin product and preparation method thereof |
| 02/18/2009 | CN101366695A Tylenol injection and preparation method thereof |
| 02/18/2009 | CN100462359C 5-sulfanyl-4H-1,2,4-triazole derivatives and their use as a medicament |
| 02/18/2009 | CN100462354C Novel 1,2-diphenylethene derivatives for treatment of immune diseases |
| 02/18/2009 | CN100462352C Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 02/18/2009 | CN100462351C Amino acids with affinity for the alpha-2-delta-protein |
| 02/18/2009 | CN100462098C Chinese medicine ointment for treating bone disease and its preparing method |
| 02/18/2009 | CN100462090C Collateral-activating pain-relieving medicine of Radix cyathulae |
| 02/18/2009 | CN100462087C Barban drug for activating collaterals and relieving pain |
| 02/18/2009 | CN100462084C Assaying method of Chinese medicine laying particle active principle and content |
| 02/18/2009 | CN100462071C Sustained release Brufen having magnetic super-molecular inserting layer structure and its preparation method |
| 02/18/2009 | CN100462069C Valproic acid derivatives for the treatment of pain. |
| 02/17/2009 | US7491825 e.g. N-[2-[4-(2-(S)-amino-6-dimethylamino-hexanoyl)-piperazin-1-yl]-1,1-dimethyl-2-oxo-ethyl]-2,4-dichloro-3-(2-methyl -quinolin-8-yloxy-methyl)-benzensulfonamide trifluoroacetate; antiinflammatory agent; asthma, chronic bronchitis, allergic rhinitis, obstructive pulmonary disease (COPD) |
| 02/17/2009 | US7491809 Polynucleotides encoding human cytokine receptor |
| 02/17/2009 | US7491746 Treating cell proliferation disorder, anticancer agents |
| 02/17/2009 | US7491741 Diaminopropionic acid derivatives |
| 02/17/2009 | US7491740 Isoxazoline compounds having MIF antagonist activity |
| 02/17/2009 | US7491739 TNF-α production inhibitors |
| 02/17/2009 | US7491734 psychotic and intellectual impairment disorders; Alzheimer's disease, cognitive or attention disorders, antidepressant, anxiolytic agent; ,smoking cessation, neuroprotection, schizophrenia, analgesia, Tourette's syndrome, and Parkinson's disease |
| 02/17/2009 | US7491730 Compositions useful as inhibitors of GSK-3 |
| 02/17/2009 | US7491677 Composite sample on support; concentration gradients |
| 02/17/2009 | US7491516 Dual specificity antibodies and methods of making and using |
| 02/17/2009 | US7491514 High specificity antibodies with reduce immunogenicity; evaluative and diagnostic tools; immunotherapy |
| 02/17/2009 | US7491410 Food grade transglutaminase inhibitor and uses thereof |
| 02/17/2009 | US7491406 Fast dissolving orally consumable films |
| 02/17/2009 | US7491392 An isolated IL-1 beta binding molecule comprising a heavy chain variable domain; treatment of an IL-1 mediated disease or disorder, e.g. osteoarthritis, osteroporosis and other inflammatory arthritis |
| 02/17/2009 | US7491047 Delivery of antihistamines through an inhalation route |
| 02/17/2009 | CA2445189C Carboline derivatives as pdev inhibitors |
| 02/17/2009 | CA2400217C Pteridine compounds for the treatment of psoriasis |
| 02/16/2009 | CA2640986A1 Therapeutic compositions for treatment of inflammation of ocular and adnexal tissues |
| 02/12/2009 | WO2009020561A2 Compositions and methods of use thereof, for the treatment of oral pain, comprising cloves or extract thereof in combination with a steroid |
| 02/12/2009 | WO2009020534A2 Method of treating cxcr3 mediated diseases using heterocyclic substituted piperazines |
| 02/12/2009 | WO2009020448A1 Proteasome inhibitors |
| 02/12/2009 | WO2009020094A1 Antibody modified with hydrophobic molecule |
| 02/12/2009 | WO2009020093A1 Immunoliposome inducing apoptosis into cell expressing death domain-containing receptor |
| 02/12/2009 | WO2009019167A1 6-amino-pyrimidine-4-carboxamide derivatives and related compounds which bind to the sphingosine 1-phosphate (s1p) receptor for the treatment of multiple sclerosis |
| 02/12/2009 | WO2009018959A1 Salts of tramadol and naproxen and their crystal forms in the treatment of pain |
| 02/12/2009 | WO2009018780A1 Andrographolide derivatives and use thereof in manufacture of medicaments |
| 02/12/2009 | WO2008071605A3 Methods of treating inflammatory diseases |
| 02/12/2009 | WO2008045663A3 Aryl-substituted heterocyclic pde4 inhibitors as antiinflammatory agents |
| 02/12/2009 | WO2008033460A3 Treating pain, diabetes, and lipid metabolism disorders |
| 02/12/2009 | US20090043129 Potent and selective ligands of cannabinoid receptors |
| 02/12/2009 | US20090042969 Use of Specific Trifluoromethyl Ketones for Preventing and Treating Pancreatitis |
| 02/12/2009 | US20090042968 Therapeutic compositions for intranasal administration of ketorolac |
| 02/12/2009 | US20090042949 Indoles Useful in the Treatment of Inflammation |
| 02/12/2009 | US20090042933 Derivatives of 4-(2-amino -1-hydroxyethyl)phenol as agonists of the Beta2 adrenergic receptor |
| 02/12/2009 | US20090042929 11-Beta-Hydroxysteroid Dehydrogenase Inhibitors |
| 02/12/2009 | US20090042920 Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 02/12/2009 | US20090042913 Indolylalkylthienopyrimidylamines as modulators of the EP2 receptor |
| 02/12/2009 | US20090042902 Hydroxyiminopiperazine compounds, used as vanilloid receptor antagonists; analgesics |
| 02/12/2009 | US20090042890 Heteroaryl compounds, compositions thereof, and methods of treatment therewith |
| 02/12/2009 | US20090042887 Methods for Preventing or Reducing the Number of Gout Flares Using Xanthine Oxidoreductase Inhibitors and Anti-Inflammatory Agents |
| 02/12/2009 | US20090042885 2-(2-((2R)-2-heptylaminomethyl-5-oxopyrrolidin-1-yl)ethylthio)-1,3-thiazole-4-carboxylic acid; EP2 and/or EP4 receptor agonist; immune disease; antiallergens; alopecia; dysmenorrhea; erectile dysfuncction; antiarthritic agents; liver, respiratory, vascular, urogenital disorder |
| 02/12/2009 | US20090042884 kinase inhibitor; immunotherapy; viricides; function or behavior associated with PI3 kinase such as cancer, immune, cardiovascular, nervous system, metabolism/endocrine and neurological diseases, viral infection, inflammation; 6-(indol-4-yl)-4-(morpholin-4-yl)-2-[(2-(pyridin-2-yl)ethylamino]pyrimidine |
| 02/12/2009 | US20090042877 such as ethyl 6-oxo-7-phenyl-3-(pyridin-3-ylamino)-6,7-dihydrothieno [2,3-b]pyridine-2-carboxylate, potent and selective inhibitors of p38 MAP kinase and are of use in the prophylaxis and treatment of immune or inflammatory disorders |
| 02/12/2009 | US20090042873 Tricyclic n-heteroaryl-carboxamide derivatives containing a benzimidazole unit, method for preparing same and their therapeutic use |
| 02/12/2009 | US20090042866 Tetrahydrocarbazoles as Active Agents for Inhibiting VEGF Production by Translational Control |
| 02/12/2009 | US20090042864 Pyrazole compounds |
| 02/12/2009 | US20090042854 Hexahydro-3H-Pyrrolizin-3-Ones Useful as Tachykinin Receptor Antagonists |
| 02/12/2009 | US20090042848 Copper complexes |
| 02/12/2009 | US20090042842 Analogues of cilostazol |
| 02/12/2009 | US20090042818 Liquiritigenin and Derivatives as Selective Estrogen Receptor Beta Agonists |